A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations

Clinical trial NCT07288580 · RECRUITING

Trial details

NCT number: NCT07288580
Sponsor: Shanghai Euhearing Therapeutics Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)

Start date: 2026-04-02
Primary completion: 2028-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.